Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Shi-hao Zhou"'
Autor:
Yu-shan Lu, Ying-ying Chen, Si-yi Ding, Li Zeng, Liang-cheng Shi, Yu-jiao Li, Jing-jing Zhang, Jin Fu, Shi-hao Zhou, Jun He
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e33437- (2024)
Background: Non-invasive prenatal tests (NIPT) are used to screen for trisomy 21, 18, and 13. This study investigated NIPT performance and the clinical significance of its results. Methods: Pregnant women (n = 282,911) participating in a free NIPT (A
Externí odkaz:
https://doaj.org/article/d431c55aa9c34740a505218bb29fa80a
Autor:
Yan‐Ping Wang, Jia‐Hui Xie, E‐Jiao Wu, Lurwanu Yahuza, Guo‐Hua Duan, Lin‐Lin Shen, Hao Liu, Shi‐Hao Zhou, Oswald Nkurikiyimfura, Björn Andersson, Li‐Na Yang, Li‐Ping Shang, Wen Zhu, Jiasui Zhan
Publikováno v:
Evolutionary Applications, Vol 13, Iss 2, Pp 318-329 (2020)
Abstract Gene flow is an important evolutionary force that enables adaptive responses of plant pathogens in response to changes in the environment and plant disease management strategies. In this study, we made a direct inference concerning gene flow
Externí odkaz:
https://doaj.org/article/27450e3887614183a0c32ae3a8878cc7
Autor:
Shi-Hao Zhou, Yu-Ting Li, Ru-Yan Zhang, Yan-Ling Liu, Zi-Wei You, Miao-Miao Bian, Yu Wen, Jian Wang, Jing-Jing Du, Jun Guo
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
The tumor-associated antigen mucin 1 (MUC1) is an attractive target of antitumor vaccine, but its weak immunogenicity is a big challenge for the development of vaccine. In order to enhance immune responses against MUC1, herein, we conjugated small mo
Externí odkaz:
https://doaj.org/article/0517683d82744606ac67b555f04e1829
Publikováno v:
Frontiers in Chemistry, Vol 10 (2022)
Mucin 1 (MUC1), a well-known tumor-associated antigen and attractive target for tumor immunotherapy, is overexpressed in most human epithelial adenomas with aberrant glycosylation. However, its low immunogenicity impedes the development of MUC1-targe
Externí odkaz:
https://doaj.org/article/d27accaeee4643ec905d356559f76d60
Autor:
Jing-Jing Du, Chang-Wei Wang, Wen-Bo Xu, Lian Zhang, Yuan-Kai Tang, Shi-Hao Zhou, Xiao-Fei Gao, Guang-Fu Yang, Jun Guo
Publikováno v:
iScience, Vol 23, Iss 3, Pp - (2020)
Summary: Many cancer vaccines are not successful in clinical trials, mainly due to the challenges associated with breaking immune tolerance. Herein, we report a new strategy using an adjuvant-protein-antigen (three-in-one protein conjugates with buil
Externí odkaz:
https://doaj.org/article/3e48a30e6b4d450ca93dda5ba1c61f46
Autor:
Ru-Yan Zhang, Shi-Hao Zhou, Ran-Ran Feng, Yu Wen, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei, Jun Guo
Publikováno v:
ACS Chemical Biology. 18:915-923
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19
Autor:
Yu Wen, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Xiao-Qian Peng, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei, Jun Guo
Publikováno v:
Journal of Controlled Release. 355:238-247
Autor:
Shi-Hao Zhou, Ru-Yan Zhang, Zi-Wei You, Yong-Ke Zou, Yu Wen, Jian Wang, Dong Ding, Miao-Miao Bian, Zhi-Ming Zhang, Hong Yuan, Guang-Fu Yang, Jun Guo
Publikováno v:
ACS Applied Materials & Interfaces. 15:8914-8926
Autor:
Dong Ding, Yu Wen, Chun-Miao Liao, Xu-Guang Yin, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Zhi-Ming Zhang, Yong-Ke Zou, Xiao-Fei Gao, Hua-Wei Wei, Guang-Fu Yang, Jun Guo
Publikováno v:
Journal of Medicinal Chemistry. 66:1467-1483
Autor:
Ru-Yan Zhang, Shi-Hao Zhou, Chen-Bin He, Jian Wang, Yu Wen, Ran-Ran Feng, Xu-Guang Yin, Guang-Fu Yang, Jun Guo
Publikováno v:
ACS Infectious Diseases. 8:1367-1375
With the global pandemic of the new coronavirus disease (COVID-19), a safe, effective, and affordable mass-produced vaccine remains the current focus of research. Herein, we designed an adjuvant-protein conjugate vaccine candidate, in which the TLR7